 | 
 | |
- February 6, 2008 - Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP » Read
- October 25, 2007 - Nile Therapeutics to Present at the Rodman & Renshaw 9th Annual Healthcare » Read
- October 18, 2007 - Nile Therapeutics Appoints Pedro Granadillo to Board of Directors » Read
- October 11, 2007 - Nile Therapeutics Announces Change to Stock Ticker Symbol » Read
- October 11, 2007 - Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure » Read
- October 2, 2007 - Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum » Read
- September 21, 2007 - Nile Therapeutics, Inc. Adds to Executive Management Team » Read
- September 18, 2007 - Nile Therapeutics, Inc. Completes $20 Million Financing and Reverse Merger with SMI Products, Inc. » Read
- May 31, 2007 - Peter M. Strumph Named CEO of Nile Therapeutics » Read
| |
|
